Robotically implanted brain-computer interface for patients with severe paralysis
Official title: PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices
Run by Neuralink Corp · NCT06429735 · Data updated 2026-11-12
This study is testing a new brain implant that uses a robot to help people with severe paralysis communicate and control devices better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 22 Years to 75 Years |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | Neuralink Corp Industry-sponsored |
| Locations | 2 sites (Phoenix, Arizona and 1 other locations) |
| Status | Recruiting |
| Started | January 9, 2024 |
| Main results expected | June 2026 |
| Study ends | January 2031 |
| Registry record updated | January 9, 2026 |
| Trial ID | NCT06429735 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals with severe quadriplegia or tetraparesis due to spinal cord injury or ALS, who have had no improvement for at least one year.
✕Probably not a fit
Patients with moderate to high risk for serious perioperative adverse events or those with active implanted devices may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The PRIME Study is an early feasibility assessment aimed at evaluating the safety and functionality of the Neuralink N1 Implant and R1 Robot in individuals suffering from severe quadriplegia or tetraparesis due to spinal cord injury or ALS. This innovative approach involves a wireless, rechargeable implant that connects to electrode threads inserted into the brain by a robotic device. The study seeks to determine how effectively this technology can restore communication and control for patients with significant motor impairments.
Why it matters
Potential benefit: If successful, this technology could significantly enhance the quality of life for patients with severe paralysis by enabling them to control devices and communicate more effectively.
How similar studies have gone: While this approach is novel, similar studies involving brain-computer interfaces have shown promise in preliminary phases.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Severe quadriplegia (tetraplegia) due to spinal cord injury or amyotrophic lateral sclerosis (ALS) for at least 1 year without improvement, where quadriplegia is defined as having very limited or no hand, wrist, and arm movement and all levels below * Life expectancy ≥ 12 months. * Ability to communicate in English * Presence of a stable caregiver Exclusion Criteria * Moderate to high risk for serious perioperative adverse events * Active implanted devices * Morbid obesity (Body Mass Index \> 40) * History of poorly controlled seizures or epilepsy * History of poorly controlled diabetes * Requires magnetic resonance imaging (MRI) for any ongoing medical conditions * Acquired or hereditary immunosuppression * Use of smoking tobacco or other tobacco products * Psychiatric or psychological disorder * Brain MRI demonstrating hemorrhage, tumor, distorted or adverse anatomy. * Any condition which, in the opinion of the Investigator, would compromise your ability to safely participate in the study or undergo the implantation procedure
Where it's running
-
Barrow Neurological Institute
Phoenix, Arizona, United States Recruiting -
University of Miami
Miami, Florida, United States Recruiting
Study contacts
- Principal investigator: Francisco Ponce, MD — Barrow Neurological Institute
- Study coordinator: Neuralink Clinical Team
- Email: clinical-team-ct@neuralink.com
- Phone: (877) 398-4465
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Robotic implantation of a precise brain‑computer interface to restore communication
This project tests whether a robotically implanted Neuralink N1 brain implant can help adults with severe, irreversible speech loss from ALS, spinal cord injury, or stroke communicate again.
-
Robotically implanted Neuralink N1 brain-computer interface to control external devices
This study will test whether a robotically implanted Neuralink N1 brain-computer interface can safely help people with high spinal cord injuries or ALS control computers and other external devices.
-
Robotically implanted brain chip to help control external devices
This tests a wireless, rechargeable brain implant (Neuralink N1) and a robot surgical system (R1) to help people with severe arm and hand paralysis control external devices.
-
Robotically implanted brain-computer interface for controlling devices
This study is testing a new brain implant and robot to see if they can help people with severe movement limitations control devices more easily.
-
Connexus® Brain-Computer Interface to restore communication and device control
This study will try the Connexus brain-computer interface to help people with severe loss of voluntary movement (for example from ALS, cervical spinal cord injury, or stroke) communicate and control computers.
-
MindEx multifocal cognitive brain‑machine interface for people with severe paralysis
This trial will test the MindEx system, which uses four tiny implanted brain chips to let people with severe paralysis control a computer or tablet with their thoughts.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.